[Federal Register: March 4, 2005 (Volume 70, Number 42)]
[Notices]
[Page 10676]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04mr05-101]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated September 28, 2004 and published in the Federal
Register on October 14, 2004, (69 FR 61043), Cambrex North Brunswick,
Inc., Technology Center of New Jersey, 661 Highway One, North
Brunswick, New Jersey 08902, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of
Phenylacetone (8501), a basic class of controlled substance listed in
Schedule II.
The company plans to import the listed controlled substances to
manufacture amphetamine.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. sections 823(a) and 952(a) and determined that
the registration of Cambrex North Brunswick, Inc. to import the basic
classes of controlled substances is consistent with the public interest
and with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Cambrex North Brunswick, Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. sections 952(a) and 958(a),
and in accordance with 21 CFR 1301.34, the above named company is
granted registration as an importer of the basic class of controlled
substance listed.
Dated: February 23, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-4235 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P